Table IV.
Item | Weekly protocol | Daily scheme |
---|---|---|
Number of adverse events | 16 (4.35) | 40 (11.36)a |
Patients with adverse events | 12/46 (26.1) | 28/44 (63.6)b |
Weight gain | 8 | 4 |
Hyperglycemia | 0 | 12 |
Hypertension | 0 | 0 |
Gastrointestinal discomfort | 4 | 8 |
Sleeplessness | 4 | 12 |
Hepatic lesion | 0 | 0 |
Renal dysfunction | 0 | 0 |
Infection | 0 | 4 |
aP<0.05 vs. weekly protocol
bP<0.01 vs. weekly protocol. Values are expressed as n, n (%) or n/total (%).